Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations

Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy that is often associated with relapse and drug resistance after standard chemotherapy or targeted therapy, particularly in older patients. Hematopoietic stem cell transplants are looked upon as the ultimate salvage option with...

Descripción completa

Detalles Bibliográficos
Autores principales: Garg, Swati, Ni, Wei, Griffin, James D., Sattler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660693/
https://www.ncbi.nlm.nih.gov/pubmed/37987319
http://dx.doi.org/10.3390/hematolrep15040063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660693/
https://www.ncbi.nlm.nih.gov/pubmed/37987319
http://dx.doi.org/10.3390/hematolrep15040063

Ejemplares similares